BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Tuesday, March 10, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
July 9, 2018
View Archived Issues
Taking the STING out of autoimmunity
Read More
Universiteit Twente presents an ITGA5-binding peptide for pancreatic cancer
Read More
New EGFR-TKI to treat T790M-mediated resistant lung cancers
Read More
Arsanis describes monoclonal antibody binding Spa and Sbi which protects against S. aureus
Read More
ETX-1317 restores the activity of cefpodoxime against beta-lactamase-producing UTI isolates
Read More
Homozygous mutation of the TALDO1 gene linked to transladolase deficiency in an adult woman
Read More
New missense variant in the FBXW11 gene associated with developmental eye and limb anomalies
Read More
Homozygous mutations in SLC10A7 gene linked to skeletal dysplasia
Read More
mAChR antagonists/beta2-adrenoceptor agonists patented by Beijing Showby Pharmaceutical
Read More
Fatty acid synthase inhibitors synthesized at Cephalon
Read More
Orion initiates phase III REFALS study of oral levosimendan for the treatment of ALS
Read More
Leo Pharma presents phosphodiesterase PDE4 inhibitors
Read More
Hangzhou Innogate Pharma divulges protein kinase inhibitors
Read More
Dual GLP-1R/GCGR agonist may help to improve the control of postprandial glucose in type 2 diabetes
Read More
Laboratorios del Dr. Esteve discovers dual mu-opioid/sigma1R ligands
Read More
New mutant EGFR inhibitors identified at Medshine Discovery
Read More
Phase II trial of ZGN-1061 in obesity and diabetes meets all primary objectives at interim analysis
Read More
Galapagos outlines phase II trial of GLPG-1205 in IPF
Read More
Benitec and Axovant sign licensing agreement for BB-301 and partner on further gene therapy programs
Read More
Incyte studies INCB-081776 for advanced solid tumors in phase I
Read More
Bayer initiates first-in-human study with BAY-1830839
Read More
Tegoprazan approved for the treatment of GERD in Korea
Read More
FDA lifts clinical hold on Invossa trials
Read More
